Current anti-copper therapies in management of Wilson disease

DOI: 10.21037/atm.2019.02.48

Keywords: Trientine (TETA), anti-copper-drugs, zinc, D-penicillamine (DPA)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text